Skip to main content
MANE
NYSE Life Sciences

SR One Capital Management Discloses 6.4% Stake in Veradermics Following IPO

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$43.7
Mkt Cap
$1.299B
52W Low
$32
52W High
$44.79
52W Position info
37% above low
Off High info
2.4% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MANE sits 37% above its 52-week low of $32.

Summary

SR One Capital Management and affiliated funds, along with Simeon George, have disclosed a 6.4% beneficial ownership stake in Veradermics, Inc. following the company's recent Initial Public Offering.


Key Events · Ownership and Investor Activity · MANE

  • Significant Ownership Stake Disclosed

    SR One Capital Management, its affiliated funds, and Simeon George now beneficially own 2,401,868 shares, representing 6.4% of Veradermics' common stock.

  • Pre-IPO Investment and IPO Participation

    The stake results from the conversion of Series C Convertible Preferred Stock, acquired in private transactions for approximately $25 million, and an additional purchase of 450,000 shares at the IPO price of $17.00 per share.

  • Investment for Long-Term Purposes

    The shares were acquired for investment purposes, with no current plans for extraordinary corporate transactions or changes in the company's board or management.

  • Subject to Lock-up Agreement

    The reporting persons are subject to a 180-day lock-up period from February 3, 2026, restricting the sale or transfer of their shares without underwriter consent.


Analysis · MANE · Life Sciences

This Schedule 13D filing provides crucial transparency regarding a significant institutional investor's foundational stake in Veradermics following its recent IPO. SR One Capital Management, a venture capital firm, converted substantial pre-IPO preferred stock holdings and participated in the IPO, demonstrating strong conviction in the company's long-term prospects. The disclosure of a major institutional investor holding over $100 million in shares (at current market price) is a positive signal, especially as the stock trades near its 52-week high. This filing complements recent Form 4 disclosures showing other directors and 10% owners also making substantial purchases post-IPO, collectively indicating robust insider and institutional confidence in the newly public company.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MANE was trading at $43.70 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $32.00 to $44.79. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MANE - Latest Insights

MANE
Nov 13, 2026, 5:39 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $129.66
Real-time Price: $124.00 info
Change: -$5.66 (-4%) info
Market Cap: $5.225B info
MANE
Nov 10, 2026, 4:57 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $148.44
Real-time Price: $124.00 info
Change: -$24.44 (-16%) info
Market Cap: $5.225B info
MANE
Nov 10, 2026, 8:54 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $142.72
Real-time Price: $124.00 info
Change: -$18.72 (-13%) info
Market Cap: $5.225B info
MANE
Nov 09, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $142.00
Real-time Price: $124.00 info
Change: -$18.00 (-13%) info
Market Cap: $5.225B info
MANE
Nov 08, 2026, 6:00 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $139.33
Real-time Price: $124.00 info
Change: -$15.33 (-11%) info
Market Cap: $5.225B info